MARYLOU NACE: Open Payments
NPI 1528244944 · FLEMINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 26 payments from 10 companies in 2025. Trend: 2023 $368 · 2024 $605 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $215 |
| Lilly USA, LLC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| HARMONY BIOSCIENCES LLC | 1 | $21 |
| Viatris Specialty LLC | 1 | $20 |
| GENZYME CORPORATION | 1 | $18 |
| Insmed, Inc. | 1 | $17 |
| Electromed, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: NUCALA, TRELEGY ELLIPTA, ZEPBOUND, INSPIRE, WAKIX, YUPELRI, DUPIXENT, Arikayce.
Industry payments across NJ — which companies pay providers there.
